Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors
- 26 October 2006
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 104 (3) , 321-329
- https://doi.org/10.1007/s10549-006-9423-5
Abstract
Background Women affected with breast cancer who carry a BRCA1 or BRCA2 (BRCA1/2) mutation are at risk of developing contralateral breast cancer. To reduce the risk of contralateral breast cancer, some patients opt for prophylactic surgery of the unaffected breast (contralateral prophylactic mastectomy, CPM) in addition to mastectomy of the affected breast. Methods We conducted the present study to determine the predictors and outcomes of CPM in the year following BRCA1/2 genetic counseling and testing. Four hundred and thirty-five women affected with unilateral breast cancer who received positive or uninformative BRCA1/2 genetic test results completed assessments prior to genetic counseling and testing and 1, 6, and 12 months after receipt of results. Results Prior to testing, 16% had undergone CPM (in conjunction with mastectomy of the affected breast). In the year following testing, 18% with positive test results and 3% with uninformative test results opted for CPM. CPM following testing was associated with a positive genetic test result, younger age at cancer diagnosis [odds ratio (OR) = 0.94], and higher cancer-specific distress at baseline (OR = 3.28). CPM was not associated with distress outcomes at 12 months. Conclusions Following a positive test result, 18% of women previously affected with unilateral breast cancer had a CPM. Women affected with breast cancer at a younger age, particularly those with positive genetic test results and higher cancer-specific distress, are more likely to choose CPM than women who receive uninformative test results and who are less distressed and older at diagnosis. CPM does not appear to impact distress outcomes.Keywords
This publication has 41 references indexed in Scilit:
- Quality of Life After Contralateral Prophylactic Mastectomy in Newly Diagnosed High-Risk Breast Cancer Patients Who Underwent BRCA1/2 Gene TestingJournal of Clinical Oncology, 2007
- Contentment With Quality of Life Among Breast Cancer Survivors With and Without Contralateral Prophylactic MastectomyJournal of Clinical Oncology, 2006
- Satisfaction After Contralateral Prophylactic Mastectomy: The Significance of Mastectomy Type, Reconstructive Complications, and Body AppearanceJournal of Clinical Oncology, 2005
- Efficacy of Prophylactic Mastectomy in Women With Unilateral Breast Cancer: A Cancer Research Network ProjectJournal of Clinical Oncology, 2005
- Contralateral Prophylactic Mastectomy: Quantifying Benefits and Weighing the HarmsJournal of Clinical Oncology, 2005
- Bilateral Prophylactic Oophorectomy and Ovarian Cancer Screening Following BRCA1/BRCA2 Mutation TestingJournal of Clinical Oncology, 2003
- Long-Term Psychological Impact of Carrying a BRCA1/2 Mutation and Prophylactic Surgery: A 5-Year Follow-Up StudyJournal of Clinical Oncology, 2003
- Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to anotherCancer, 2001
- Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer.Health Psychology, 1999
- Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer.Health Psychology, 1995